Product Categories
| Country: | United States |
|---|---|
| Tel: | +1-781-999-5354 |
| Mobile: | +1-00000000000 |
| E-mail: | marketing@targetmol.com |
| QQ: | |
| Skype: | Chat Now! |
| Address: | 36?Washington?Street, Wellesley?Hills |
|
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
|
|
| Product Name | MF | CAS | Details |
|---|
| Galidesivir triphosphate；BCX6870;Immucillin-A triphosphate;BCX4430-triphosphate | C11H18N5O12P3 | 1467740-78-8 | Details |
| G3-C12 | C74H115N23O23S2 | 848301-94-0 | Details |
| GABAB receptor antagonist 1 | C18H24O4 | 797-17-1 | Details |
| GABAA receptor agent 1 | C13H8ClN3O2 | 1571-87-5 | Details |
| Galanthamine N-Oxide | C17H21NO4 | 134332-50-6 | Details |
| G6PD activator AG1 | C24H30N4S2 | 421581-52-4 | Details |
| Taurocholic acid sodium salt hydrate；Taurocholic Acid sodium hydrate;Sodium taurocholate hydrate | C26H46NNaO8S | 345909-26-4 | Details |
| GDC-0927；SRN-927 | C28H28FNO4 | 1642297-01-5 | Details |
| GDP366 | C20H17N5OS | 501698-03-9 | Details |
| GDP-?α-D-?mannose disodium | C16H23N5Na2O16P2 | 148296-46-2 | Details |
| Pictilisib dimethanesulfonate | C24H30N7O6S3 | 957054-33-0 | Details |
| Gemcabene calcium；PD-72953 calcium | C16H32CaO5 | 209789-08-2 | Details |
| Gefitinib N-oxide | C22H24ClFN4O4 | 847949-51-3 | Details |
| Gefitinib-d8；ZD1839 D8;Gefitinib D8 | C22H24ClFN4O3 | 857091-32-8 | Details |
| GCN2iB | C18H12ClF2N5O3S | 2183470-12-2 | Details |
| GCN2-IN-6 | C19H12Cl2F2N4O3S | 2183470-09-7 | Details |
| GCN2-IN-1 | C19H18N10O | 1448693-69-3 | Details |
| GC7 Sulfate | C8H22N4O4S | 150417-90-6 | Details |
| Clorsulon | C8H8Cl3N3O4S2 | 60200-06-8 | Details |
| Garcinol | C38H50O6 | 78824-30-3 | Details |
| Gastrofensin AN 5 free base | C19H21ClN2O2 | 89845-16-9 | Details |
| GATA4-NKX2-5-IN-1 | C21H23N3O2 | 544681-96-1 | Details |
| Ganoderic acid TR | C30H44O4 | 862893-75-2 | Details |
| Ganoderic acid F | C32H42O9 | 98665-15-7 | Details |
| Amylase | 9000-92-4 | Details |
| gamma-secretase modulator 1 | C24H24N4OS | 1172637-87-4 | Details |
| Gallopamil hydrochloride | C28H41ClN2O5 | 16662-46-7 | Details |
| Gallopamil | C28H40N2O5 | 16662-47-8 | Details |
| GC 14 | C26H27NO6 | 447415-34-1 | Details |
| GDC-0276 | C24H31FN2O4S | 1494581-70-2 | Details |
| GDC-0834 S-enantiomer | C33H36N6O3S | 1133432-50-4 | Details |
| GDC-0834 Racemate | C33H36N6O3S | 1133432-46-8 | Details |
| Gambogellic acid | C38H44O8 | 173867-04-4 | Details |
| Gamitrinib TPP | C52H65N3O8P+ | 1131626-46-4 | Details |
| Gamitrinib TPP hexafluorophosphate | C52H65F6N3O8P2 | 1131626-47-5 | Details |
| Gamma-glutamylcysteine TFA；Gamma-glutamylcysteine (TFA);γ-glutamylcysteine (TFA) | C20H32N6O12S2 | 283159-88-6 | Details |
| gamma-secretase modulator 2 | C25H22F4N6O2 | 1093978-89-2 | Details |
| gamma-secretase modulator 3 | C24H23FN4OS | 1431697-84-5 | Details |
| γ-Secretase modulator 4 | C23H19FN4O2 | 1420200-82-3 | Details |
| GB-110 | C33H48N6O5 | 1252806-70-4 | Details |
| GB-88 | C32H42N4O4 | 1416435-96-5 | Details |
| GBR 12783 | C28H32N2O | 67469-57-2 | Details |
| GDC-0834 | C33H36N6O3S | 1133432-49-1 | Details |
| Lerociclib | C26H34N8O | 1628256-23-4 | Details |
| Lerociclib dihydrochloride | C26H35ClN8O | 2097938-59-3 | Details |
| gamma-Secretase Modulators；Amyloid-β production inhibitor;γ-Secretase Modulators | C26H24F3N3O3 | 937812-80-1 | Details |
| Ganodermanontriol | C30H48O4 | 106518-63-2 | Details |
| G907 | C26H24ClNO3 | 2244035-16-1 | Details |
| Clindamycin phosphate | C18H34ClN2O8PS | 24729-96-2 | Details |
| IPN60090 | C24H27F3N8O3 | 1853164-83-6 | Details |
| Glutaminase-IN-1；CB839 derivative | C26H24F3N7O3Se | 2247127-79-1 | Details |
| GLUT4 activator 1 | C23H21FN4O3S | 2253733-37-6 | Details |
| O6BTG-octylglucoside；Glucose-conjugated MGMT inhibitor | C24H34BrN5O7S | 382607-78-5 | Details |
| Fenbendazole | C15H13N3O2S | 43210-67-9 | Details |
| GLPG1205 | C22H22N2O4 | 1445847-37-9 | Details |
| GLPG0492 | C19H14F3N3O3 | 1215085-92-9 | Details |
| GLP-26 | C19H17F2N3O3 | 2133017-36-2 | Details |
| GLPG0492 (R enantiomer)；GLPG0492 R enantiomer | C19H14F3N3O3 | 1215085-93-0 | Details |
| Salbutamol；AH-3365;Albuterol | C13H21NO3 | 18559-94-9 | Details |
| Genz-123346 | C52H82N4O14 | 943344-58-9 | Details |
| Gemfibrozil 1-O-β-glucuronide | C21H30O9 | 91683-38-4 | Details |
| GFB-8438 | C16H14ClF3N4O2 | 2304549-73-1 | Details |
| GGTI-2418 | C23H31N5O4 | 501010-06-6 | Details |
| Ginsenoside Ra3 | C59H100O27 | 90985-77-6 | Details |
| GENZ-882706；RA03546849 | C26H25N5O3 | 2070864-35-4 | Details |
| Gepotidacin；GSK2140944 | C24H28N6O3 | 1075236-89-3 | Details |
| Germacrene D | C15H24 | 23986-74-5 | Details |
| GF 15 | C23H21ClO6 | 888042-13-5 | Details |
| GGTI298 | C27H33N3O3S | 180977-44-0 | Details |
| Giredestrant；GDC-9545 | C27H31F5N4O | 1953133-47-5 | Details |
| Doxycycline hydrochloride；Hyclate;Vibramycin;Doxylin | C22H25ClN2O8 | 10592-13-9 | Details |
| Glutaminyl Cyclase Inhibitor 3 | C24H32N6O2S | 2092921-50-9 | Details |
| Glucagon receptor antagonists-5 | C30H29ClF3N3O3 | 2200274-63-9 | Details |
| Glucagon receptor antagonists-3 | C22H30FNO2 | 202917-17-7 | Details |
| Glucagon receptor antagonists-2 | C22H30FNO2 | 202917-18-8 | Details |
| Glucagon receptor antagonists-1 | C29H34FNO2 | 503559-84-0 | Details |
| Glucocorticoid receptor agonist | C20H20F4N2O2 | 1245526-82-2 | Details |
| Glucokinase activator 1 | C27H20F2N2O7S2 | 1328987-85-4 | Details |
| Gisadenafil besylate；UK 369003-26 | C29H39N7O8S2 | 334827-98-4 | Details |
| GKA50 | C26H28N2O6 | 851884-87-2 | Details |
| Gln-AMS | C15H22N8O8S | 209543-57-7 | Details |
| GLP-1 receptor agonist 3 | C31H30FN5O4 | 2230200-09-4 | Details |
| GLP-1 receptor agonist 4 | C51H44Cl2N4O6 | 1187061-62-6 | Details |
| TT-OAD2 free base | C50H47Cl2N3O6 | 1246826-07-2 | Details |
| GLP-1 receptor agonist 2 | C30H31ClFN5O4 | 2230197-64-3 | Details |
| GLP-1 receptor agonist 1 | C48H48F2N10O5 | 2212020-52-3 | Details |
| GET73 | C13H16F3NO2 | 202402-01-5 | Details |
| Gemilukast | C36H37F2NO5 | 1232861-58-3 | Details |
| Gemcabene | C16H30O5 | 183293-82-5 | Details |
| Glycolic acid oxidase inhibitor 1 | C16H10BrNO3 | 77529-42-1 | Details |
| Gly-β-MCA | C26H43NO6 | 66225-78-3 | Details |
| Glyco-Obeticholic acid | C28H47NO5 | 863239-60-5 | Details |
| Antibacterial compound 2 | C22H30FN5O6 | 170104-58-2 | Details |
| Glutaminyl Cyclase Inhibitor 2 | C19H20FN3 | 1884546-29-5 | Details |
| Glutaminyl Cyclase Inhibitor 1 | C21H24FN3O2 | 2110449-60-8 | Details |
| Glutaminyl Cyclase Inhibitor 4 | C22H33N5O3 | 2376329-36-9 | Details |
| Carbenicillin disodium | C17H19N2NaO6S | 4800-94-6 | Details |
| Glyoxalase I inhibitor free base | C21H29BrN4O8S | 174568-92-4 | Details |
| Glycosidase-IN-2 | C13H23NO5 | 476310-39-1 | Details |
| Glycosidase-IN-1 | C13H23NO5 | 170376-12-2 | Details |
| Product Total： Product Page： | ||||
| 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 | ||||